These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 28534372

  • 1. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
    Jin Z, Jin RH, Ma C, Li HS, Xu HY.
    J BUON; 2017; 22(2):474-480. PubMed ID: 28534372
    [Abstract] [Full Text] [Related]

  • 2. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J, Wang T, Zhang Y, Wang H, Wu Y, Liu K, Pei C.
    Cancer Biomark; 2018 Jul 30; 21(4):763-768. PubMed ID: 29286916
    [Abstract] [Full Text] [Related]

  • 4. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 30; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 30; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 6. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K, Chaniad P, Geater SL, Keeratichananont W, Chittithavorn V, Uttayamakul S, Buya S, Raungrut P, Thongsuksai P.
    Cancer Biol Med; 2020 Aug 15; 17(3):652-663. PubMed ID: 32944397
    [Abstract] [Full Text] [Related]

  • 7. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ, Zheng YH, Wang P, Zhang JZ.
    Int J Clin Exp Pathol; 2015 Aug 15; 8(1):765-71. PubMed ID: 25755772
    [Abstract] [Full Text] [Related]

  • 8. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
    Wang K, Dong L, Fang Q, Xia H, Hou X.
    Cancer Biomark; 2017 Sep 07; 20(3):283-288. PubMed ID: 28946561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
    Zhang YL, Zhang ZL, Zhu XB, Xu L, Lu P, Xu M, Liu WJ, Zhang XY, Yao HM, Ye XW.
    Eur Rev Med Pharmacol Sci; 2019 Jun 07; 23(12):5251-5259. PubMed ID: 31298376
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, Liu X, Le H, Zhang Y.
    PLoS One; 2016 Jun 07; 11(4):e0153046. PubMed ID: 27093275
    [Abstract] [Full Text] [Related]

  • 15. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W, Zhang Y, Zhang Y, Shi Y, Xi J, Fan H, Xu S.
    Int J Mol Med; 2015 Dec 07; 36(6):1720-6. PubMed ID: 26497897
    [Abstract] [Full Text] [Related]

  • 16. Predicative values of serum microRNA-22 and microRNA-126 levels for non-small cell lung cancer development and metastasis: a case-control study.
    Shang AQ, Xie YN, Wang J, Sun L, Wei J, Lu WY, Lan JY, Wang WW, Wang L, Wang LL.
    Neoplasma; 2017 Dec 07; 64(3):453-459. PubMed ID: 28253725
    [Abstract] [Full Text] [Related]

  • 17. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL, Chen Y, Sun Y, Yin YJ, Song CX.
    Clin Lab; 2017 Jan 01; 63(1):133-140. PubMed ID: 28164492
    [Abstract] [Full Text] [Related]

  • 18. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G, Zhang J, Chen X.
    J Drug Target; 2016 Aug 01; 24(7):613-7. PubMed ID: 26581116
    [Abstract] [Full Text] [Related]

  • 19. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017 Aug 01; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.